Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease [3]

Annals of Hematology

Volumn 87, Issue 5, 2008, Pages 421-423

  Chung, Lo Woei ^a   Yeh, Su Peng ^a   Hsieh, Ching Yun ^a   Liao, Yu Min ^a   Huang, Hsin Hui ^a   Lin, Chen Yuan ^a   Chiu, Chang Fang ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; IDARUBICIN; PREDNISOLONE; THALIDOMIDE;

ACUTE GRAFT REJECTION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE PANCREATITIS; ADOLESCENT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LOW DRUG DOSE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADOLESCENT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, ACUTE; PANCREATITIS; THALIDOMIDE; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41549090511     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0410-7     Document Type: Letter

References (11)

1. Schneider DT, Nurnberger W, Stannigel H, Bonig H, Gobel U (1999) Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation. Gut 45:733-736
2. Ko CW, Gooley T, Schoch HG, Myerson D, Hackman RC, Shulman HM et al (1997) Acute pancreatitis in marrow transplant patients: Prevalence at autopsy and risk factor analysis. Bone Marrow Transplant 20:1081-1086
3. Shore T, Bow E, Greenberg H, Persad R, Patterson D, Rubinger M et al (1996) Pancreatitis post-bone marrow transplantation. Bone Marrow Transplant 17:1181-1184
4. Werlin SL, Casper J, Antonson D, Calabro C (1992) Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Transplant 10:65-69
5. Dimopoulos MA, Eleutherakis-Papaiakovou V (2004) Adverse effects of thalidomide administration in patients with neoplastic diseases. Am J Med 117:508-515
6. Trojan A, Chasse E, Gay B (2003) Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma. Ann Oncol 14:501-502
7. Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR et al (2002) Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol 20:4319-4323
8. Mehta P, Kedar A, Graham-Pole J, Skoda-Smith S, Wingard JR (1999) Thalidomide in children undergoing bone marrow transplantation: Series at a single institution and review of the literature. Pediatrics 103:44-48
9. Mallory A, Kern Jr F (1980) Drug-induced pancreatitis: A critical review. Gastroenterology 78:813-820
10. Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175:76-83
11. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J (1992) Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 33:1126-1128